GSK's Arexvy and Pfizer's Abrysvo are approved for the prevention of lower respiratory tract disease caused by RSV in adults aged 50 to 59 and 18 to 59, respectively, who are at an increased risk of ...

In a court filing on Wednesday, lawyers for the AP accused the White House of continuing to exclude its journalists from the ...

AMD confirmed on Wednesday that the export control applies to its MI308 products. A U.S. Commerce Department spokesperson ...